Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
CLZNY.US
id: 950, Created by , Scout

Clariant (CLZNY) Accounting Irregularities Review Case

  • In February 2022, Clariant delayed 2021 results due to an internal investigation of accounting practices.
  • $CLZNY fell 15.7%, losing $1B+ of shareholder value.
  • Investors may have grounds to suspect Clariant of presenting inaccurate statements, which led to their losses.
On February 14, 2022, Clariant (CLZNY) disclosed the delay of the release of Q4 and 2021 financial results due to an internal investigation into accounting matters for 2020 and 2021. It reviewed employees' accounting practices that might have distorted results to meet internal and external targets.

On this news, $CLZNY fell 15.7% and lost over $1 billion of its market capitalization, seriously damaging shareholders.

Considering all the information, investors might have grounds to suspect that Clariant and its executives failed to disclose and correct distortive accounting practices, which consequently led to their losses.

The case is already under investigation by at least one of the reputable law firms.
Alleged Offence
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
14 February 2022
Collecting participants…

Clariant AG

Clariant AG develops, manufactures, distributes, and sells specialty chemicals worldwide. The Care Chemicals segment offers specialty chemicals and application solutions for various applications in...

    Ticker
    CLZNY.US
    ISIN
    US18047P1012
    CIK
    1366235
    Sector
    Basic Materials
    Industry
    Specialty Chemicals
    Country
    USA
    Address
    Rothausstrasse 61, Muttenz, Switzerland, 4132